论文部分内容阅读
目的:讨论老年消化道溃疡伴出血患者采用兰索拉唑与注射用血凝酶联合进行治疗的临床效果。方法:选择在我院接受治疗的52例老年消化道溃疡伴出血患者,随机将其分为对照组和治疗组。对照组采用兰索拉唑进行治疗;治疗组采用兰索拉唑与注射用血凝酶联合进行治疗。比较两组患者治疗效果的差异。结果:治疗组患者有1例药物原因导致的不良反应,与对照组1例药物不良反应比较,无显著性差异(P>0.05);消化功能恢复正常时间和药物治疗总时间短于对照组,差异显著(P<0.05);老年消化道溃疡伴出血药物治疗在治疗组总有效率达到92.3%,高于对照组的80.8%,组间差异显著(P<0.05)。结论:老年消化道溃疡伴出血患者采用兰索拉唑与注射用血凝酶联合进行治疗,能提高疗效,缩短疗程,且药物不良反应无明显增加。
Objective: To discuss the clinical effect of lansoprazole combined with injection of hemagglutinin in elderly patients with peptic ulcer and hemorrhage. Methods: 52 elderly patients with peptic ulcer and hemorrhage who were treated in our hospital were randomly divided into control group and treatment group. The control group was treated with lansoprazole. The treatment group was treated with lansoprazole and hemagglutinin for injection. The difference between the two groups was compared. Results: There was 1 case of drug-induced adverse reactions in the treatment group, which was not significantly different from 1 case of adverse drug reaction in the control group (P> 0.05). The normal time of digestive function recovery and the total duration of drug treatment were shorter than those in the control group, (P <0.05). The total effective rate of the treatment of peptic ulcer with hemorrhage in the treatment group was 92.3%, which was higher than that of the control group (80.8%), the difference was significant (P <0.05). Conclusion: The combination of lansoprazole and injection of hemagglutinin in elderly patients with peptic ulcer and hemorrhage can improve the curative effect, shorten the course of treatment, and no obvious increase of adverse drug reactions.